OnKure Therapeutics, Inc. (OKUR)
2.95
-0.01
(-0.34%)
USD |
NASDAQ |
Sep 18, 16:00
2.95
0.00 (0.00%)
After-Hours: 20:00
OnKure Therapeutics Total Assets (Quarterly) : 179.35M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 179.35M |
| March 31, 2026 | 198.69M |
| December 31, 2025 | 62.12M |
| September 30, 2025 | 72.84M |
| June 30, 2025 | 86.07M |
| March 31, 2025 | 99.88M |
| December 31, 2024 | 114.91M |
| September 30, 2024 | 77.64M |
| June 30, 2024 | 78.72M |
| March 31, 2024 | 84.64M |
| December 31, 2023 | 35.73M |
| September 30, 2023 | 130.39M |
| Date | Value |
|---|---|
| June 30, 2023 | 148.04M |
| March 31, 2023 | 98.87M |
| December 31, 2022 | 108.18M |
| September 30, 2022 | 122.50M |
| June 30, 2022 | 133.61M |
| March 31, 2022 | 144.41M |
| December 31, 2021 | 154.02M |
| September 30, 2021 | 162.94M |
| June 30, 2021 | 171.30M |
| March 31, 2021 | 95.32M |
| December 31, 2020 | 55.22M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.245M |
| Shareholders Equity (Quarterly) | 172.11M |
| Debt to Equity Ratio | 0.0054 |
| Current Ratio | 26.75 |
| Net Debt Paydown Yield | 0.00% |